ANIMATION

Apoptosis and BCL-2

Share this article with:

ABT-199/GDC-0199 is a small molecule drug in co-development by Abbvie and Genentech for the selective inhibition of BCL-2, a key regulator of cellular apoptosis. BCL-2, part of the larger BCL-2 family, is responsible for the sequestration of pro-apoptopic proteins along the mitochondrial membrane. Displacement of these proteins from BCL-2 in cancerous cells may prime these cells for apoptosis.

Share It:
Contact XVIVO

Client


Abbvie; Genentech

XVIVO really came through for us when we were putting together animations for the Health gallery of the Connecticut Science Center. The beating heart is gorgeous! They are true experts and we really enjoyed collaborating with them.

Shannon Densmore, Executive Producer, Boston Productions, INC.